CD-Chex Plus BC by Streck Inc.

Manufacturer Streck Inc.
CD-Chex Plus BC is a positive procedural control for immunophenotyping by flow cytometry on Beckman Coulter flow cytometry systems. It is assayed for 30 parameters including T-lymphocytes, B-lymphocytes, granulocytes, monocytes, NK cells and a normal level of CD34+ cells. The whole blood control is available in two clinically relevant levels of CD4+ cells.


CD-Chex Plus BC by Streck Inc. product image
CD-Chex Plus BC
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

CD-Chex Plus BC is a positive procedural control for monitoring immunophenotyping by flow cytometry on Beckman Coulter flow cytometry instruments. It provides 30 assayed CD parameters on a single control, including T-lymphocytes, B-lymphocytes, granulocytes, monocytes, and NK cells. It is available in two clinically relevant levels of CD4+ cells and is assayed for a normal level of CD34+ cells. Designed to mimic a patient sample, CD-Chex Plus BC is manufactured from normal human peripheral blood leukocytes and erythrocytes. The whole blood control offers 30-day open-vial stability. CD-Chex Plus BC features cap pierceable plastic vials for use with automated flow cytometry sample preparation instruments, reducing errors and improving laboratory workflow.

It is a positive procedural control designed to verify the accuracy and reproducibility of the steps involved in the process of the immunophenotyping including reagent staining, erythrocyte lysis, sample preparation, and instrument performance. CD-Chex Plus BC is designed for use on Beckman Coulter flow cytometry systems.

Features

  • Assayed for 30 parameters
  • Available in two clinically relevant levels of CD4+ cells
  • Assayed for a normal level of CD34+ cells
  • Designed for use on Beckman Coulter flow cytometry systems
  • 30-day open-vial stability
  • 90-day closed-vial stability

Benefits

  • Helps laboratory meet CLIA guidelines
  • Established assay ranges provide less room for error
  • Reduces the need for labs to hold and validate patient samples for use as a control
  • Access to STATS®, a free interlaboratory quality control program with peer group data comparison and online submission